WNBA reaches media rights deal to air games on ION
June 13 - ION will continue to air WNBA regular-season games on Friday nights after the league and Scripps reached a multi-year media rights deal.
Terms of the deal -- which will take effect for the 2026 season -- were not disclosed.
"This new multi-year agreement reflects the growing excitement surrounding the league and the rising demand for WNBA games," WNBA commissioner Cathy Engelbert said in a statement. "Through Scripps' ION Network Friday Night doubleheaders, we will continue to showcase the world-class talent of WNBA athletes to even more fans nationwide."
ION began airing WNBA game on Friday nights in 2023, with the initial three-year agreement between ION reportedly worth $13 million annually.
In its opening Friday this season, former UConn star Paige Bueckers' debut with the Dallas Wings drew an average of 639,000 viewers, and the league debut of the Golden State Valkyries drew an average of 581,000 viewers, per The Athletic.
The May 30 matchup between the Indiana Fever and the Connecticut Sun averaged 851,000 viewers, making it the most-watched WNBA game without Caitlin Clark in the network's history, according to SportsMediaWatch. As of the end of May, ION has seen year-over-year average viewership increase 39 percent to average 550,000, per SMW.
The WNBA also broadcasts games on CBS and has an 11-year media rights package with Disney, NBC and Amazon that takes effect next season worth an average of $200 million a year.
Members of the Women's National Basketball Players Association (WNBPA) were reportedly not included in the negotiations with Scripps, according to Front Office Sports.
Commissioner Engelbert had previously expressed support for the players' union being represented at the table for such discussions, which a union source acknowledged was "unprecedented" but said the WNBPA is "hopeful" can happen in future negotiations, according to Front Office Sports.
--Field Level Media
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
19 minutes ago
- Daily Mail
Surprise contender emerges to be New Orleans Saints' starting QB in 2025
The Saints' quarterback situation is reportedly less straightforward than previously believed. Following the sudden retirement of Derek Carr, many assumed that Tyler Shough was the presumptive starter given that he was selected in the second round of this year's NFL Draft. And while the former Louisville passer may in fact win the starting job, ESPN's Dan Graziano believes there will be a 'true competition' in training camp between Shough and Spencer Rattler. '...There are people in the Saints' building who like Spencer Rattler and want to give him a chance to compete with Shough for the starting job,' Graziano wrote. 'And so far this offseason, Rattler has shown improvement over his poor 2024 rookie performance. 'As of now, expect the Saints to set up training camp as a true competition between Shough and Rattler. Could Shough have the edge as the player the new coaching staff drafted with the 40th pick? Absolutely. But it doesn't sound like anything is already a done deal.' Shough, 25, spent a whopping seven years in the college ranks, playing for the likes of Oregon and Texas Tech before finishing out his collegiate career with Louisville last year. Derek Carr announced his retirement from the NFL in sudden fashion back in May And the passer had by far his best season there, notching a career-high 3,195 passing yards and 23 touchdowns. Rattler, whom the Saints selected in the fifth round of the 2024 Draft, is actually a year younger than Shough. Due to injuries to Carr, Rattler got the chance to make six starts last season, in which he averaged 197 yards per game and totaled three passing touchdowns to five interceptions. New Orleans lost all six of his starts. Carr, who also suffered an oblique injury in October, saw his season prematurely end on December 8 due to a concussion and a left-hand injury. He began throwing again in March after his 2024 season ended, but soon began experiencing discomfort in his throwing shoulder. Subsequent medical scans revealed 'significant degenerative changes to his rotator cuff,' according to the Saints. And although surgery was an option, it would have put his entire 2025 season in jeopardy - and still wouldn't ensure a return to full strength. Ultimately, the 34-year-old decided in May to call it quits. 'Upon reflection of prayer, and in discussion with Heather, I've decided to retire from the National Football League,' Carr said in his statement. 'For more than 11 years, we have been incredibly blessed, and we are forever grateful and humbled by this experience. 'It's difficult to find the right words to express our thanks to all the teammates, coaches, management, ownership, team officials and especially the fans who made this journey so special. Your unwavering support has meant the world to us.' The Saints will open up their 2025 season on September 7 against the Cardinals.
The Guardian
29 minutes ago
- The Guardian
Grilled cheese shop offers Minnesotans a second chance after prison
All Square, a neon-lit diner in Minneapolis, specializes in grilled cheese sandwiches with a twist. Variations on the menu include Jamaican jerk chicken with guava jam, brown sugar bacon doused in ranch dressing, and Granny Smith apple slices coated in brie and mozzarella. But the sandwich shop offers more than elevated comfort food. All Square, which also operates a food-truck catering service, exclusively hires formerly incarcerated Minnesotans. 'It started with the idea of: how do we respond to this systemic issue of excluding formerly incarcerated folks from, well, everything once we welcome them home?' said Emily Hunt Turner, a civil rights lawyer who founded the restaurant in 2018. The name All Square refers to the shape of the grilled cheese sandwich as well as the idea that those who served their time deserve a chance to restart their lives with a clean slate. Hunt Turner, 41, said she built the menu around grilled cheese in part because the relatively low overhead allows her to focus on her true mission: supporting people coming home from prison. Each year, Hunt Turner and her team hire five full-time fellows who were recently released from prison. Over the next year, those workers cook, clean and serve tables, earning up to $23 per hour, including tips. When they're not working at the restaurant, the fellows have access to a host of services, including therapy and workshops aimed at helping them launch their own businesses. Taqee Abdul-Hakim, a fellow from the 2022 class, began working at the restaurant just one month after he was released from prison. He said the free therapy sessions helped clear his mind and dream bigger. The weekly paychecks allowed him to find an apartment and provide for his two young children, even enrolling one in gymnastics. Just as importantly, he said, flipping sandwiches with other formerly incarcerated people helped him stay out of trouble. 'I needed to reshape my friend group after I got out,' Abdul-Hakim said. 'At All Square, it was nice to have those types of friends who are in the same position as me, who have been through it but trying to better our lives at the same time.' All Square is part of a broader social enterprise of the same name. The non-profit, which has 25 employees and a $3m annual operating budget, also runs a law firm that provides services to justice-impacted Minnesotans and helps incarcerated people train in the law. Hunt Turner founded All Square after working as an attorney for the US Department of Housing and Urban Development, where she saw first-hand how difficult it was for people with criminal histories to access housing. 'We were getting complaints from all over the country where folks were saying they're being discriminated against on the basis of having a criminal record,' she said. 'This kind of perpetual punishment is not something we can turn away from.' An estimated 70 million Americans, about one in three adults, has an arrest or conviction on their record. They face high rates of homelessness and steep barriers to employment. One in three formerly incarcerated people is unemployed, according to federal statistics, and being without a job doubles the odds of returning to prison. 'We heard a lot from fellows that outstanding debt – child support arrears, student loan debt, traffic citations – can be such a barrier to starting over,' Turner said. 'So we established a debt-alleviation fund that dispenses up to $2,000 in debt relief as they transition to the next chapter of their lives.' To build the restaurant, Turner raised $250,000 from a Kickstarter campaign and a Minneapolis Foundation grant; she also sold a few dozen $1,000 memberships to the 'Grilled Cheese for Life' club. Revenues from the restaurant support the organization's other operations. 'The magic ingredient of All Square is that it's not dependent on fundraising or donors,' said Bruce Reilly, a founding board member of the organization and an advocate for the formerly incarcerated. 'People might not write you a $1,000 check, but they might come buy a sandwich every day for the next 10 years.' The sandwiches are a hit, but some local groups question whether All Square is the best vehicle to support the Black and brown communities that are disproportionately involved with the justice system. 'Because it's not founded or directed by justice-impacted people, it's not equipped to help our community through re-entry,' said Kevin Reese, co-founder and co-executive director of the local organization Until We Are All Free. Turner said the issue of representation and privilege is something the organization wrestles with constantly as it expands in size and ambition. 'From our perspective, broad-based support and allyship are vital to forging social movements,' she said. The program has graduated 56 fellows and provided $130,000 in debt relief and seed capital, Turner said. Graduates have gone on to launch a coffee importer and a custom grills shop, among other enterprises. Abdul-Hakim, the 2022 fellow, used a $10,000 seed capital grant from All Square to launch a towing company, Mow-Tow. In addition to earning a living wage at the restaurant, he said the fellowship taught him how to create a business plan and build up his credit. 'If I didn't come across All Square, to be honest, I don't think I'd be down the path I'm on now,' he said.
The Independent
an hour ago
- The Independent
The cost of staying alive could become a lot more expensive for millions of Americans because of Trump drug tariffs
Americans would likely pay more for necessary everyday prescription drugs, such as insulin, painkillers, chemotherapy, or antibiotics, if President Donald Trump were to enact tariffs on pharmaceuticals, experts warn. In an effort to incentivize drug manufacturers to bring production back to the United States, Trump has proposed tariffing pharmaceuticals made overseas – which account for an overwhelming majority of everyday medicine used in the U.S. 'We're going to be doing that,' Trump said of pharmaceutical tariffs in April. 'That's going to be like we have on cars. You know we have a 25 percent tariff on cars, we have a 25 percent tariff on steel and aluminum, and that's what the [pharmaceutical] category fits right now.' 'The higher the tariff, the faster they come,' Trump said. But experts say that's not necessarily true and there would be tangible consequences to such action, from higher brand-name drug prices to generic drug shortages. 'If tariffs were applied to prescription drugs, one of the most immediate consequences could be price increases — on prices that we already pay way in excess of other countries,' Dr. Mariana Socal, an associate professor at the Johns Hopkins Bloomberg School of Public Health, said. The U.S. imports a majority of its branded prescription drugs – or medications that are patented with a brand name such as Viagra, Wegovy, or Zoloft – from high-income countries. Dr. Jeromie Ballreich, an associated research professor at Johns Hopkins Bloomberg School of Public Health, said much of the manufacturing comes from Ireland, Germany, and Switzerland because they have favorable tax policies for companies. As a result, adding a tariff would only make it more expensive for pharmacies and insurance companies to keep them in supply. 'We would expect pharma to pass the costs onto the insurers and we would expect insurers to pass the cost onto the individual patients,' Ballreich said. 'So, if there is a 50 percent tariff on your insulin product because it's coming from Ireland, patients in Mississippi who get insulin – they will either be faced with a higher cost when they go up to the pharmacy to fill their insulin or they're going to face a higher indirect cost because the premiums of the insurance plan are going to go up,' he said. Ballreich said a tariff on countries that produce high quantities of branded drugs would put 'pressure' on public insurers like Medicare or Medicaid and private insurers. However, branded drugs only account for roughly 10 to 15 percent of prescriptions. A majority of Americans, up to 90 percent, use generic drugs, often manufactured in India and China, because they're cheaper. Making branded drugs less accessible through tariffs would only increase reliance on generic drugs, which could exacerbate shortages that already impact millions of Americans. Generic drugs would become less available '[Shortages] can have very significant implications in day-to-day clinical practice,' Socal said. 'For example, if you are administering chemotherapy for an oncology patient, that may have significant consequences even for the prognosis of that case moving forward.' In 2024, the U.S. experienced a shortage of more than 300 drugs – 70 percent of which were generic prescriptions. Socal said that when patients are not able to access a more affordable version of their prescription, it means they may put their health at risk by skipping a dosage, taking a lower dosage, or not filling their prescription at all. Otherwise, they're forced to turn to the more expensive branded version. 'Those more expensive drugs are not always the best,' Socal said. 'Very frequently, and we saw this with chemotherapy shortages, the available drugs are second-line drugs.' Tariffs won't necessarily increase domestic manufacturing The president has indicated that any negative impact from tariffs may be temporary and worth it to bring manufacturing and jobs back. 'We're doing it because we want to make our own drugs,' Trump said. But Ballreich and Socal are more skeptical. 'Tariffs are a very blunt instrument to incentivize domestic U.S. manufacturing of the branded drugs we use,' Ballreich said. Given pharmaceutical companies have moved outside of the U.S. for tax purposes, Ballreich says tax policy may be a better way to incentivize them, especially since many of those drugs are more difficult to manufacture. 'It's not just a very simple chemical plant; these tend to be very complex,' he said. Socal suggested a better strategy would be to understand where drugs are being manufactured and which ones would make more sense to bring to the U.S. — since even those manufactured locally often rely on certain imported ingredients and materials. 'Having tariffs on pharmaceutical products coming from abroad can actually also hurt our domestic manufacturers,' he says. While the president has not officially implemented any tariff policy on pharmaceuticals yet, he said, in April, that the plan would take effect in the 'not too distant future.'
